1. Metabolic Enzyme/Protease Stem Cell/Wnt Neuronal Signaling Apoptosis
  2. PAI-1 Ser/Thr Protease Furin MMP Notch Apoptosis
  3. TM5614 sodium

TM5614 sodium is an orally active and specific PAI-1 inhibitor with an IC50 of <6.95 μM. TM5614 sodium blocks the interaction between PAI-1 and serine proteases or LRP-1, and enhances plasmin generation. TM5614 sodium restores macrophage efferocytosis and promotes macrophage polarization. TM5614 sodium alleviates PAI-1-mediated inhibition of Furin, promotes MT1-MMP maturation, activates the NOTCH1 signaling pathway, inhibits proliferation and induces apoptosis. TM5614 sodium promotes skeletal muscle regeneration and alleviates inflammation in a mouse model of skeletal muscle injury. TM5614 sodium can be used in research on skeletal muscle injury-induced inflammation and chronic myeloid leukemia.

For research use only. We do not sell to patients.

TM5614 sodium

TM5614 sodium Chemical Structure

CAS No. : 1247823-40-0

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

TM5614 sodium is an orally active and specific PAI-1 inhibitor with an IC50 of <6.95 μM. TM5614 sodium blocks the interaction between PAI-1 and serine proteases or LRP-1, and enhances plasmin generation. TM5614 sodium restores macrophage efferocytosis and promotes macrophage polarization. TM5614 sodium alleviates PAI-1-mediated inhibition of Furin, promotes MT1-MMP maturation, activates the NOTCH1 signaling pathway, inhibits proliferation and induces apoptosis. TM5614 sodium promotes skeletal muscle regeneration and alleviates inflammation in a mouse model of skeletal muscle injury. TM5614 sodium can be used in research on skeletal muscle injury-induced inflammation and chronic myeloid leukemia[1][2].

In Vitro

TM5614 (2 h) sodium enhances efferocytosis in mouse bone marrow-derived CCR2+Ly6C+ macrophages and J774.1-GFP cells via an LRP-1-dependent mechanism[1].
TM5614 (62.7 μM; 72 h) sodium exerts direct anti-tumor effects on PAI-1/K562-1 and PAI-1/K562-2 chronic myeloid leukemia cells by inhibiting proliferation, inducing apoptosis, and regulating the Furin/NICD signaling pathway[2].
TM5614 sodium upregulates the protein expression level of Furin and enhances the expression level of MT1-MMP on the cell surface[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[2]

Cell Line: PAI-1/K562-1 and PAI-1/K562-2 cells
Concentration: 62.7 μM
Incubation Time: 72 h
Result: Significantly increased the proportion of early and late apoptosis.
In Vivo

TM5614 (10 mg/kg; p.o.; daily; for 3-7 consecutive days) sodium promotes skeletal muscle regeneration and alleviates inflammation in a cardiotoxin (CTX)-induced mouse model of skeletal muscle injury by downregulating pro-inflammatory cytokine expression, upregulating anti-inflammatory cytokine expression, and accelerating tissue repair. It enhances the phagocytic activity of macrophages (as a surrogate marker of efferocytosis), increasing the dextran uptake rate of macrophages by 14.5 percentage points[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6J (12- to 20-week-old male; CTX-induced skeletal muscle injury)[1]
Dosage: 10 mg/kg
Administration: p.o.; daily; 7 consecutive days/ daily; 3 consecutive days
Result: Reduced relative mRNA expression of pro-inflammatory cytokines TNF-α, IL-1β, IFN-γ, and CCL2 in injured TA muscle on day 4 post-CTX injection.
Increased relative mRNA expression of anti-inflammatory cytokine IL-10 in injured TA muscle on day 4 post-CTX injection.
Accelerated disappearance of EBD blue staining in injured TA muscle by day 8 post-CTX injection.
Increased number of mature/restored skeletal myofibers in injured TA muscle by day 8 post-CTX injection.
Increased the percentage of CD45+CD11b+ macrophages in injured TA muscle that took up TRITC-labeled dextran from 23.9% to 38.4%.
Molecular Weight

424.81

Formula

C23H14ClN2NaO3

CAS No.
SMILES

O=C(C1=CC(Cl)=CC=C1NC(C2=CC=CC(C3=C4N=CC=CC4=CC=C3)=C2)=O)O[Na]

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
TM5614 sodium
Cat. No.:
HY-183626
Quantity:
MCE Japan Authorized Agent: